Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 502 entries
Sorted by: Best Match Show Resources per page
Neuroimaging studies of alexithymia: physical, affective, and social perspectives.

BioPsychoSocial medicine

Moriguchi Y, Komaki G.
PMID: 23537323
Biopsychosoc Med. 2013 Mar 28;7(1):8. doi: 10.1186/1751-0759-7-8.

Alexithymia refers to difficulty in identifying and expressing one's emotions, and it is related to disturbed emotional regulation. It was originally proposed as a personality trait that plays a central role in psychosomatic diseases. This review of neuroimaging studies...

Cite
Moriguchi Y, Komaki G. Neuroimaging studies of alexithymia: physical, affective, and social perspectives. Biopsychosoc Med. 2013;7(1):8doi: 10.1186/1751-0759-7-8.
Moriguchi, Y., & Komaki, G. (2013). Neuroimaging studies of alexithymia: physical, affective, and social perspectives. BioPsychoSocial medicine, 7(1), 8. https://doi.org/10.1186/1751-0759-7-8
Moriguchi, Yoshiya, and Komaki, Gen. "Neuroimaging studies of alexithymia: physical, affective, and social perspectives." BioPsychoSocial medicine vol. 7,1 (2013): 8. doi: https://doi.org/10.1186/1751-0759-7-8
Moriguchi Y, Komaki G. Neuroimaging studies of alexithymia: physical, affective, and social perspectives. Biopsychosoc Med. 2013 Mar 28;7(1):8. doi: 10.1186/1751-0759-7-8. PMID: 23537323; PMCID: PMC3621096.
Copy Download .nbib Format: NLM
The juggling paradigm: a novel social neuroscience approach to identify neuropsychophysiological markers of team mental models.

Frontiers in psychology

Filho E, Bertollo M, Robazza C, Comani S.
PMID: 26113837
Front Psychol. 2015 Jun 11;6:799. doi: 10.3389/fpsyg.2015.00799. eCollection 2015.

Since the discovery of the mirror neuron system in the 1980s, little, if any, research has been devoted to the study of interactive motor tasks (Goldman, 2012). Scientists interested in the neuropsychophysiological markers of joint motor action have relied...

Cite
Filho E, Bertollo M, Robazza C, et al. The juggling paradigm: a novel social neuroscience approach to identify neuropsychophysiological markers of team mental models. Front Psychol. 2015;6:799doi: 10.3389/fpsyg.2015.00799.
Filho, E., Bertollo, M., Robazza, C., & Comani, S. (2015). The juggling paradigm: a novel social neuroscience approach to identify neuropsychophysiological markers of team mental models. Frontiers in psychology, 6799. https://doi.org/10.3389/fpsyg.2015.00799
Filho, Edson, et al. "The juggling paradigm: a novel social neuroscience approach to identify neuropsychophysiological markers of team mental models." Frontiers in psychology vol. 6 (2015): 799. doi: https://doi.org/10.3389/fpsyg.2015.00799
Filho E, Bertollo M, Robazza C, Comani S. The juggling paradigm: a novel social neuroscience approach to identify neuropsychophysiological markers of team mental models. Front Psychol. 2015 Jun 11;6:799. doi: 10.3389/fpsyg.2015.00799. eCollection 2015. PMID: 26113837; PMCID: PMC4462642.
Copy Download .nbib Format: NLM
Synthesis and controllable oxidation of monodisperse cobalt-doped wüstite nanoparticles and their core-shell stability and exchange-bias stabilization.

Nanoscale

Chen CJ, Chiang RK, Kamali S, Wang SL.
PMID: 26243163
Nanoscale. 2015 Sep 14;7(34):14332-43. doi: 10.1039/c5nr02969d.

Cobalt-doped wüstite (CWT), Co0.33Fe0.67O, nanoparticles were prepared via the thermal decomposition of CoFe2-oleate complexes in organic solvents. A controllable oxidation process was then performed to obtain Co0.33Fe0.67O/CoFe2O4 core-shell structures with different core-to-shell volume ratios and exchange bias properties. The...

Cite
Chen CJ, Chiang RK, Kamali S, et al. Synthesis and controllable oxidation of monodisperse cobalt-doped wüstite nanoparticles and their core-shell stability and exchange-bias stabilization. Nanoscale. 2015;7(34):14332-43doi: 10.1039/c5nr02969d.
Chen, C. J., Chiang, R. K., Kamali, S., & Wang, S. L. (2015). Synthesis and controllable oxidation of monodisperse cobalt-doped wüstite nanoparticles and their core-shell stability and exchange-bias stabilization. Nanoscale, 7(34), 14332-43. https://doi.org/10.1039/c5nr02969d
Chen, Chih-Jung, et al. "Synthesis and controllable oxidation of monodisperse cobalt-doped wüstite nanoparticles and their core-shell stability and exchange-bias stabilization." Nanoscale vol. 7,34 (2015): 14332-43. doi: https://doi.org/10.1039/c5nr02969d
Chen CJ, Chiang RK, Kamali S, Wang SL. Synthesis and controllable oxidation of monodisperse cobalt-doped wüstite nanoparticles and their core-shell stability and exchange-bias stabilization. Nanoscale. 2015 Sep 14;7(34):14332-43. doi: 10.1039/c5nr02969d. PMID: 26243163.
Copy Download .nbib Format: NLM
Implementing intensified tuberculosis case-finding among street-connected youth and young adults in Kenya.

Public health action

Szkwarko D, Mercer T, Kimani S, Braitstein P, Buziba N, Carter EJ.
PMID: 27358809
Public Health Action. 2016 Jun 21;6(2):142-6. doi: 10.5588/pha.16.0021.

BACKGROUND: Street-connected youth and young adults (SCY) suffer a myriad of health problems. In Kenya, SCY are at high risk for tuberculosis (TB) due to their congregate living situations. TB screening is not routinely implemented in SCY and there...

Cite
Szkwarko D, Mercer T, Kimani S, et al. Implementing intensified tuberculosis case-finding among street-connected youth and young adults in Kenya. Public Health Action. 2016;6(2):142-6doi: 10.5588/pha.16.0021.
Szkwarko, D., Mercer, T., Kimani, S., Braitstein, P., Buziba, N., & Carter, E. J. (2016). Implementing intensified tuberculosis case-finding among street-connected youth and young adults in Kenya. Public health action, 6(2), 142-6. https://doi.org/10.5588/pha.16.0021
Szkwarko, D, et al. "Implementing intensified tuberculosis case-finding among street-connected youth and young adults in Kenya." Public health action vol. 6,2 (2016): 142-6. doi: https://doi.org/10.5588/pha.16.0021
Szkwarko D, Mercer T, Kimani S, Braitstein P, Buziba N, Carter EJ. Implementing intensified tuberculosis case-finding among street-connected youth and young adults in Kenya. Public Health Action. 2016 Jun 21;6(2):142-6. doi: 10.5588/pha.16.0021. PMID: 27358809; PMCID: PMC4913678.
Copy Download .nbib Format: NLM
The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial.

Iranian journal of microbiology

Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, Alikhani MY, Roshanaie G, Komaki S.
PMID: 26668706
Iran J Microbiol. 2015 Jun;7(3):173-7.

BACKGROUND AND OBJECTIVE: The aim of the study was to evaluate the clinical effects of a mouthwash containing Sage (Salvia officinalis) extracts on Streptococcus mutans (SM) causing dental plaque in school-aged children.MATERIAL AND METHODS: A double blind clinical trial...

Cite
Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, et al. The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iran J Microbiol. 2015;7(3):173-7
Beheshti-Rouy, M., Azarsina, M., Rezaie-Soufi, L., Alikhani, M. Y., Roshanaie, G., & Komaki, S. (2015). The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iranian journal of microbiology, 7(3), 173-7.
Beheshti-Rouy, Maryam, et al. "The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial." Iranian journal of microbiology vol. 7,3 (2015): 173-7.
Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, Alikhani MY, Roshanaie G, Komaki S. The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iran J Microbiol. 2015 Jun;7(3):173-7. PMID: 26668706; PMCID: PMC4676988.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A.

Genome announcements

Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y.
PMID: 26659677
Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01430-15.

Nonomuraea sp. TP-A0861 produces the nonribosomal peptide myxochelin A, which is known as a microbial siderophore. Here, we report its draft genome sequence. The genome contains at least three nonribosomal peptide synthetase gene clusters, one of which is proposed...

Cite
Komaki H, Ichikawa N, Hosoyama A, et al. Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01430-15.
Komaki, H., Ichikawa, N., Hosoyama, A., Fujita, N., & Igarashi, Y. (2015). Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01430-15
Komaki, Hisayuki, et al. "Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01430-15
Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y. Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01430-15. PMID: 26659677; PMCID: PMC4675942.
Copy Download .nbib Format: NLM
Presentation of new classification of perceived risk factors and etiologies of cardiovascular diseases.

ARYA atherosclerosis

Komasi S, Saeidi M.
PMID: 28607570
ARYA Atheroscler. 2016 Nov;12(6):295-296.

No abstract available.

Cite
Komasi S, Saeidi M. Presentation of new classification of perceived risk factors and etiologies of cardiovascular diseases. ARYA Atheroscler. 2016;12(6):295-296
Komasi, S., & Saeidi, M. (2016). Presentation of new classification of perceived risk factors and etiologies of cardiovascular diseases. ARYA atherosclerosis, 12(6), 295-296.
Komasi, Saeid, and Saeidi, Mozhgan. "Presentation of new classification of perceived risk factors and etiologies of cardiovascular diseases." ARYA atherosclerosis vol. 12,6 (2016): 295-296.
Komasi S, Saeidi M. Presentation of new classification of perceived risk factors and etiologies of cardiovascular diseases. ARYA Atheroscler. 2016 Nov;12(6):295-296. PMID: 28607570; PMCID: PMC5455329.
Copy Download .nbib Format: NLM
Transcatheter aortic valve replacement: The year in review 2016.

Journal of interventional cardiology

Harjai KJ, Grines CL, Paradis JM, Kodali S.
PMID: 28569413
J Interv Cardiol. 2017 Jun;30(3):286. doi: 10.1111/joic.12394.

No abstract available.

Cite
Harjai KJ, Grines CL, Paradis JM, et al. Transcatheter aortic valve replacement: The year in review 2016. J Interv Cardiol. 2017;30(3):286doi: 10.1111/joic.12394.
Harjai, K. J., Grines, C. L., Paradis, J. M., & Kodali, S. (2017). Transcatheter aortic valve replacement: The year in review 2016. Journal of interventional cardiology, 30(3), 286. https://doi.org/10.1111/joic.12394
Harjai, Kishore J, et al. "Transcatheter aortic valve replacement: The year in review 2016." Journal of interventional cardiology vol. 30,3 (2017): 286. doi: https://doi.org/10.1111/joic.12394
Harjai KJ, Grines CL, Paradis JM, Kodali S. Transcatheter aortic valve replacement: The year in review 2016. J Interv Cardiol. 2017 Jun;30(3):286. doi: 10.1111/joic.12394. PMID: 28569413.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces.

Genome announcements

Komaki H, Ichikawa N, Oguchi A, Hamada M, Tamura T, Fujita N.
PMID: 25657283
Genome Announc. 2015 Feb 05;3(1). doi: 10.1128/genomeA.01527-14.

Streptomyces albus is the type species of the genus Streptomyces. Here, we report the draft genome sequence of S. albus strain NBRC 13014(T). The genome contains at least seven orphan polyketide synthase and nonribosomal peptide synthetase gene clusters. The...

Cite
Komaki H, Ichikawa N, Oguchi A, et al. Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces. Genome Announc. 2015;3(1)doi: 10.1128/genomeA.01527-14.
Komaki, H., Ichikawa, N., Oguchi, A., Hamada, M., Tamura, T., & Fujita, N. (2015). Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces. Genome announcements, 3(1), . https://doi.org/10.1128/genomeA.01527-14
Komaki, Hisayuki, et al. "Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces." Genome announcements vol. 3,1 (2015). doi: https://doi.org/10.1128/genomeA.01527-14
Komaki H, Ichikawa N, Oguchi A, Hamada M, Tamura T, Fujita N. Draft Genome Sequence of Streptomyces albus Strain NBRC 13014T, the Type Species of the Genus Streptomyces. Genome Announc. 2015 Feb 05;3(1). doi: 10.1128/genomeA.01527-14. PMID: 25657283; PMCID: PMC4319605.
Copy Download .nbib Format: NLM
Optogenetics applications for treating spinal cord injury.

Asian spine journal

Ahmad A, Ashraf S, Komai S.
PMID: 25901246
Asian Spine J. 2015 Apr;9(2):299-305. doi: 10.4184/asj.2015.9.2.299. Epub 2015 Apr 15.

Cases of spinal cord injury (SCI) are increasing all over the world; and in USA alone, there are 273,000 patients, which not only leads to morbidity and mortality but also results in a great economic burden. Many approaches are...

Cite
Ahmad A, Ashraf S, Komai S. Optogenetics applications for treating spinal cord injury. Asian Spine J. 2015;9(2):299-305doi: 10.4184/asj.2015.9.2.299.
Ahmad, A., Ashraf, S., & Komai, S. (2015). Optogenetics applications for treating spinal cord injury. Asian spine journal, 9(2), 299-305. https://doi.org/10.4184/asj.2015.9.2.299
Ahmad, Aftab, et al. "Optogenetics applications for treating spinal cord injury." Asian spine journal vol. 9,2 (2015): 299-305. doi: https://doi.org/10.4184/asj.2015.9.2.299
Ahmad A, Ashraf S, Komai S. Optogenetics applications for treating spinal cord injury. Asian Spine J. 2015 Apr;9(2):299-305. doi: 10.4184/asj.2015.9.2.299. Epub 2015 Apr 15. PMID: 25901246; PMCID: PMC4404549.
Copy Download .nbib Format: NLM
The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases.

Frontiers in oncology

Chi A, Nguyen NP, Komaki R.
PMID: 25009800
Front Oncol. 2014 Jun 25;4:151. doi: 10.3389/fonc.2014.00151. eCollection 2014.

Image guidance allows delivery of very high doses of radiation over a few fractions, known as stereotactic ablative radiotherapy (SABR). This treatment is associated with excellent outcome for early stage non-small cell lung cancer and metastases to the lungs....

Cite
Chi A, Nguyen NP, Komaki R. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol. 2014;4:151doi: 10.3389/fonc.2014.00151.
Chi, A., Nguyen, N. P., & Komaki, R. (2014). The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Frontiers in oncology, 4151. https://doi.org/10.3389/fonc.2014.00151
Chi, Alexander, et al. "The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases." Frontiers in oncology vol. 4 (2014): 151. doi: https://doi.org/10.3389/fonc.2014.00151
Chi A, Nguyen NP, Komaki R. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol. 2014 Jun 25;4:151. doi: 10.3389/fonc.2014.00151. eCollection 2014. PMID: 25009800; PMCID: PMC4070060.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin.

Genome announcements

Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y.
PMID: 26659684
Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01446-15.

Here, we report the draft genome sequence of Streptomyces sp. TP-A0356, a producer of a potent antitumor antibiotic, yatakemycin, to evaluate potential for secondary metabolite production. The genome sequence data suggest the presence of at least nine gene clusters...

Cite
Komaki H, Ichikawa N, Hosoyama A, et al. Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01446-15.
Komaki, H., Ichikawa, N., Hosoyama, A., Fujita, N., & Igarashi, Y. (2015). Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01446-15
Komaki, Hisayuki, et al. "Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01446-15
Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y. Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin. Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01446-15. PMID: 26659684; PMCID: PMC4675949.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 502 entries